Asset Dedication LLC’s INmune Bio INMB Stock Holding History

Asset Dedication LLC’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-814	Closed	-$6K	–	1017
2023 Q3	$6K	Hold	814	–	–	﹤0.01%	757
2023 Q2	$7K	Hold	814	–	–	﹤0.01%	718
2023 Q1	$5K	Hold	814	–	–	﹤0.01%	752
2022 Q4	$5K	Hold	814	–	–	﹤0.01%	757
2022 Q3	$5K	Hold	814	–	–	﹤0.01%	714
2022 Q2	$7K	Hold	814	–	–	﹤0.01%	370
2022 Q1	$7K	Hold	814	–	–	﹤0.01%	698
2021 Q4	$8K	Hold	814	–	–	﹤0.01%	675
2021 Q3	$16K	Hold	814	–	–	﹤0.01%	607
2021 Q2	$14K	Hold	814	–	–	﹤0.01%	569
2021 Q1	$10K	Hold	814	–	–	﹤0.01%	505
2020 Q4	$14K	Buy	+814	New	+$7.67K	﹤0.01%	510

Other funds holding INMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

QCG

Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Asset Dedication LLC's INMB Position: Q4 2023 in Review

Asset Dedication LLC sold out of INmune Bio (INMB) in Q4 2023, closing a stake of 814 shares — an estimated $6K sold.

Asset Dedication LLC first reported a position in INMB in Q4 2020 and held it in 12 quarters. The position peaked at $16K in Q3 2021. 48 funds tracked by Wall St. Rank hold INMB as of Q4 2023.

Asset Dedication LLC reported no remaining INmune Bio position as of Q4 2023 after selling out during the quarter.
Asset Dedication LLC sold 814 INmune Bio shares in Q4 2023, an estimated $6K.
Asset Dedication LLC first reported a position in INmune Bio in Q4 2020 and held it in 12 quarters.
Asset Dedication LLC's INmune Bio position peaked at $16K in Q3 2021.
48 funds tracked by Wall St. Rank held INmune Bio as of Q4 2023.

Based on Asset Dedication LLC's 13F filing for Q4 2023, filed 8 Feb 2024.